The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph - acute lymphoblastic leukemia cells

Anna Scuto, Mark Kirschbaum, Claudia Kowolik, Leo Kretzner, Agnes Juhasz, Peter Atadja, Vinod Pullarkat, Ravi Bhatia, Stephen Forman, Yun Yen, Richard Jove

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

We investigated the mechanism of action of LBH589, a novel broad-spectrum HDAC inhibitor belonging to the hydroxamate class, in Philadelphia chromosome-negative (Ph -) acute lymphoblastic leukemia (ALL). Two model human Ph - ALL cell lines (T-cell MOLT-4 and pre-B-cell Reh) were treated with LBH589 and evaluated for biologic and gene expression responses. Low nanomolar concentrations (IC 50:5-20 nM) of LBH589 induced cell-cycle arrest, apoptosis, and histone (H3K9 and H4K8) hyperacetylation. LBH589 treatment increased mRNA levels of proapoptosis, growth arrest, and DNA damage repair genes including FANCG, FOXO3A, GADD45A, GADD45B, and GADD45G. The most dramatically expressed gene (up to 45-fold induction) observed after treatment with LBH589 is GADD45G. LBH589 treatment was associated with increased histone acetylation at the GADD45G promoter and phosphorylation of histone H2A.X. Furthermore, treatment with LBH589 was active against cultured primary Ph -ALL cells, including those from a relapsed patient, inducing loss of cell viability (up to 70%) and induction of GADD45G mRNA expression (up to 35-fold). Thus, LBH589 possesses potent growth inhibitory activity against including Ph - ALL cells associated with up-regulation of genes critical for DNA damage response and growth arrest. These findings provide a rationale for exploring the clinical activity of LBH589 in the treat-ment of patients with Ph - ALL

Original languageEnglish
Pages (from-to)5093-5100
Number of pages8
JournalBlood
Volume111
Issue number10
DOIs
Publication statusPublished - May 15 2008
Externally publishedYes

Fingerprint

Histone Deacetylase Inhibitors
Precursor Cell Lymphoblastic Leukemia-Lymphoma
DNA Damage
Genes
Apoptosis
DNA
Cells
Histones
Growth
panobinostat
Acetylation
Philadelphia Chromosome
Messenger RNA
Phosphorylation
B-Lymphoid Precursor Cells
T-cells
Therapeutics
Chromosomes
Cell Cycle Checkpoints
Gene expression

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph - acute lymphoblastic leukemia cells. / Scuto, Anna; Kirschbaum, Mark; Kowolik, Claudia; Kretzner, Leo; Juhasz, Agnes; Atadja, Peter; Pullarkat, Vinod; Bhatia, Ravi; Forman, Stephen; Yen, Yun; Jove, Richard.

In: Blood, Vol. 111, No. 10, 15.05.2008, p. 5093-5100.

Research output: Contribution to journalArticle

Scuto, A, Kirschbaum, M, Kowolik, C, Kretzner, L, Juhasz, A, Atadja, P, Pullarkat, V, Bhatia, R, Forman, S, Yen, Y & Jove, R 2008, 'The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph - acute lymphoblastic leukemia cells', Blood, vol. 111, no. 10, pp. 5093-5100. https://doi.org/10.1182/blood-2007-10-117762
Scuto, Anna ; Kirschbaum, Mark ; Kowolik, Claudia ; Kretzner, Leo ; Juhasz, Agnes ; Atadja, Peter ; Pullarkat, Vinod ; Bhatia, Ravi ; Forman, Stephen ; Yen, Yun ; Jove, Richard. / The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph - acute lymphoblastic leukemia cells. In: Blood. 2008 ; Vol. 111, No. 10. pp. 5093-5100.
@article{0a889ac1090d427988dbc7e15cc4a98b,
title = "The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph - acute lymphoblastic leukemia cells",
abstract = "We investigated the mechanism of action of LBH589, a novel broad-spectrum HDAC inhibitor belonging to the hydroxamate class, in Philadelphia chromosome-negative (Ph -) acute lymphoblastic leukemia (ALL). Two model human Ph - ALL cell lines (T-cell MOLT-4 and pre-B-cell Reh) were treated with LBH589 and evaluated for biologic and gene expression responses. Low nanomolar concentrations (IC 50:5-20 nM) of LBH589 induced cell-cycle arrest, apoptosis, and histone (H3K9 and H4K8) hyperacetylation. LBH589 treatment increased mRNA levels of proapoptosis, growth arrest, and DNA damage repair genes including FANCG, FOXO3A, GADD45A, GADD45B, and GADD45G. The most dramatically expressed gene (up to 45-fold induction) observed after treatment with LBH589 is GADD45G. LBH589 treatment was associated with increased histone acetylation at the GADD45G promoter and phosphorylation of histone H2A.X. Furthermore, treatment with LBH589 was active against cultured primary Ph -ALL cells, including those from a relapsed patient, inducing loss of cell viability (up to 70{\%}) and induction of GADD45G mRNA expression (up to 35-fold). Thus, LBH589 possesses potent growth inhibitory activity against including Ph - ALL cells associated with up-regulation of genes critical for DNA damage response and growth arrest. These findings provide a rationale for exploring the clinical activity of LBH589 in the treat-ment of patients with Ph - ALL",
author = "Anna Scuto and Mark Kirschbaum and Claudia Kowolik and Leo Kretzner and Agnes Juhasz and Peter Atadja and Vinod Pullarkat and Ravi Bhatia and Stephen Forman and Yun Yen and Richard Jove",
year = "2008",
month = "5",
day = "15",
doi = "10.1182/blood-2007-10-117762",
language = "English",
volume = "111",
pages = "5093--5100",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "10",

}

TY - JOUR

T1 - The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph - acute lymphoblastic leukemia cells

AU - Scuto, Anna

AU - Kirschbaum, Mark

AU - Kowolik, Claudia

AU - Kretzner, Leo

AU - Juhasz, Agnes

AU - Atadja, Peter

AU - Pullarkat, Vinod

AU - Bhatia, Ravi

AU - Forman, Stephen

AU - Yen, Yun

AU - Jove, Richard

PY - 2008/5/15

Y1 - 2008/5/15

N2 - We investigated the mechanism of action of LBH589, a novel broad-spectrum HDAC inhibitor belonging to the hydroxamate class, in Philadelphia chromosome-negative (Ph -) acute lymphoblastic leukemia (ALL). Two model human Ph - ALL cell lines (T-cell MOLT-4 and pre-B-cell Reh) were treated with LBH589 and evaluated for biologic and gene expression responses. Low nanomolar concentrations (IC 50:5-20 nM) of LBH589 induced cell-cycle arrest, apoptosis, and histone (H3K9 and H4K8) hyperacetylation. LBH589 treatment increased mRNA levels of proapoptosis, growth arrest, and DNA damage repair genes including FANCG, FOXO3A, GADD45A, GADD45B, and GADD45G. The most dramatically expressed gene (up to 45-fold induction) observed after treatment with LBH589 is GADD45G. LBH589 treatment was associated with increased histone acetylation at the GADD45G promoter and phosphorylation of histone H2A.X. Furthermore, treatment with LBH589 was active against cultured primary Ph -ALL cells, including those from a relapsed patient, inducing loss of cell viability (up to 70%) and induction of GADD45G mRNA expression (up to 35-fold). Thus, LBH589 possesses potent growth inhibitory activity against including Ph - ALL cells associated with up-regulation of genes critical for DNA damage response and growth arrest. These findings provide a rationale for exploring the clinical activity of LBH589 in the treat-ment of patients with Ph - ALL

AB - We investigated the mechanism of action of LBH589, a novel broad-spectrum HDAC inhibitor belonging to the hydroxamate class, in Philadelphia chromosome-negative (Ph -) acute lymphoblastic leukemia (ALL). Two model human Ph - ALL cell lines (T-cell MOLT-4 and pre-B-cell Reh) were treated with LBH589 and evaluated for biologic and gene expression responses. Low nanomolar concentrations (IC 50:5-20 nM) of LBH589 induced cell-cycle arrest, apoptosis, and histone (H3K9 and H4K8) hyperacetylation. LBH589 treatment increased mRNA levels of proapoptosis, growth arrest, and DNA damage repair genes including FANCG, FOXO3A, GADD45A, GADD45B, and GADD45G. The most dramatically expressed gene (up to 45-fold induction) observed after treatment with LBH589 is GADD45G. LBH589 treatment was associated with increased histone acetylation at the GADD45G promoter and phosphorylation of histone H2A.X. Furthermore, treatment with LBH589 was active against cultured primary Ph -ALL cells, including those from a relapsed patient, inducing loss of cell viability (up to 70%) and induction of GADD45G mRNA expression (up to 35-fold). Thus, LBH589 possesses potent growth inhibitory activity against including Ph - ALL cells associated with up-regulation of genes critical for DNA damage response and growth arrest. These findings provide a rationale for exploring the clinical activity of LBH589 in the treat-ment of patients with Ph - ALL

UR - http://www.scopus.com/inward/record.url?scp=46749139575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46749139575&partnerID=8YFLogxK

U2 - 10.1182/blood-2007-10-117762

DO - 10.1182/blood-2007-10-117762

M3 - Article

C2 - 18349321

AN - SCOPUS:46749139575

VL - 111

SP - 5093

EP - 5100

JO - Blood

JF - Blood

SN - 0006-4971

IS - 10

ER -